On October 29 the U.S. Food and Drug Administration Announced that it will be implementing what it calls a “Plant and Animal Biotechnology Innovation Action Plan” that is scheduled to be rolled out in phases in 2019 through 2020. The action plan aims to implement and clarify risk-based policies with the goals of ensuring that developers know what they need to do to efficiently bring a product to market, and that consumers and the public understand how the FDA’s regulatory system helps ensure the safety of such products. The Action Plan identifies concrete priorities in three key areas:
- Advancing public health by promoting innovation
- Strengthening public outreach and communication
- Increasing engagement with domestic and international partners
A copy of the action plan can be found here.